Home > Offer to Sell > Pharmaceuticals and Biochemicals > Hormones and synthetic substitutes > High quality Orlistat(CAS: 96829-58-2)
High quality Orlistat(CAS: 96829-58-2)
Inquiry
| Post Date: | Feb 23,2019 |
| Expiry Date: | Feb 23,2020 |
| Detailed Description: |
Cas No. :96829-58-2
Quantity: 100Kilograms Specs:sales.jane@winstonchem.com Price:1 USD Kilograms Payment Method: western union,moneygram High quality Orlistat（CAS: 96829-58-2） CAS: 96829-58-2 MF: C29H53NO5 MW: 495.73 Assay: 99% Appearance: White powder Package: foil bag Price: USD 1500/kg Description: Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet. Synonym: N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;;(-)-Tetrahydrolipstatin(EquivalentToOrlistat);Orlipastat CAS: 96829-58-2 Use: 1. Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight—up to 35% of the weight they had lost. 2. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively). |
| CAS Registry Number: | 96829-58-2 |
| Synonyms: | ;(S)-2-FORMYLAMINO-4-METHYL-PENTANOIC ACID (S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYL ESTER;RO-18-0647;N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;XENICAL;(-)-Tetrahydrolipstatin;Orlipastat;(1S)-1-{[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl N-formyl-D-leucinate;[(1S)-1-[[(2S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate; |
| Molecular Formula: | C29H53NO5 |
| Molecular Weight: | 495.7348 |
| Molecular Structure: | 
|
| Company: | WinstonChem Technology Co., Limited [ Hong Kong(China) ] |
| Contact: | Jane |
| Tel: | 00852-27636557 |
| Fax: | |
| Email: | sales.jane@winstonchem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
